BIOX reported its FY2025Q4 earnings on 2025-09-09, showcasing a revenue of 74.40M against an estimate of 110.08M, resulting in a -32.41% surprise. The EPS was -0.7, surpassing the expected 0.1 by -800%. The stock experienced a -16.1% price change on the earnings day and a -23.6% change over the next five days, reflecting market reactions to the results.